for the ketamine Abbreviated New Drug Application, which was assigned a Generic Drug User Fee Amendments of 2022 ("GDUFA”) goal date of October 29, 2024. On November 12, 2024, the FDA granted the ...

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

Aerobic exercise has been linked with Parkinson's disease progression and risk. ( Washington Post) Air purifiers in residential aged-care facilities did not reduce the incidence of acute respiratory ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting CD46, in combination with enzalutamide in patients with me ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Advertisement He wrote that the law is "facially unconstitutional" and "in all applications" that will "irreparably harm ...

Arkansas researchers are testing a product commonly used to treat ticks and fleas on pets to target fly and mosquito larvae ...